01521.HK
Frontage Holdings Corporation
HKSE · Healthcare · Biotechnology · US
HKD 1.03
−2.83%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 12.07x
- P/E 2027E
- 11.23x
- P/E 2028E
- 13.02x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 25.25x
- PEG TTM
- —
- Price / book
- 0.75x
- Price / sales
- 0.96x
- Price / cash flow
- 5.24x
Enterprise value
- Enterprise value
- HKD 2.9B
- EV / sales
- 1.34x
- EV / EBITDA
- 6.97x
- EV / EBIT
- 17.02x
- Market cap
- HKD 2.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026